Indeferimento
#9.2
03/24/2026
RPI 2881
Application data
Number
112019006504Type
Filing
Publication
PCT
IB2017056160 The application was refused by the INPI on 03/24/2026. The invention was never patented.
Talk to a specialistLatest action published by the INPI: 03/24/2026. We update with every new RPI gazette, published weekly.
Applicants
MERCK PATENT GMBH
DE
PFIZER INC.
US
Inventors
C. B. (pessoa física)
US
G. A. (pessoa física)
US
P. G. (pessoa física)
CH
S. B. (pessoa física)
US
S. W. (pessoa física)
DE
IPC Classification
Priority claims
US
62/405,188 · 10/06/2016
US
62/565,728 · 09/29/2017
Abstract
A presente invenção refere-se ao regime de dosagem de avelumabe para o tratamento de câncer. Em particular, a invenção refere-se a um regime de dosagem aprimorado do avelumabe para o tratamento de câncer.
Publications in the Brazilian Industrial Property Gazette (RPI).
#9.2
03/24/2026
RPI 2881
#7.1
11/11/2025
RPI 2862
#6.23
01/10/2023
RPI 2714
#15.35
10/05/2021
RPI 2648
#1.3
06/25/2019
RPI 2529
#1.1
04/09/2019
RPI 2518
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.